© 2021 CVR Life Sciences Pvt. Ltd.
| S. No | Product Name | Intermediate Name | CAS Number | Status |
|---|---|---|---|---|
| 1 | Apixaban | 1-(4-Nitrophenyl)piperidin-2-one | 38560-30-4 | Commercial |
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 | Commercial | ||
| (1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone) | 1267610-26-3 | Commercial | ||
| Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 / 473927-63-8 | Commercial | ||
| 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone | 545445-44-1 | Commercial | ||
| Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503614-91-3 | Commercial | ||
| 2 | Rivaroxaban | (R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione | 446292-07-5 | Commercial |
| (S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione | 446292-08-6 | Commercial | ||
| (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 | Commercial | ||
| 3 | Edoxaban | tert-Butyl (1R,2S,5S)-5-(dimethylcarbamoyl)-2-aminocyclohexylcarbamate | 365998-36-3 | Tech Pack |
| tert-Butyl (1R,2S,5S)-5-(dimethylcarbamoyl)-2-aminocyclohexylcarbamate oxalate | 1210348-34-7 | Tech Pack | ||
| Ethyl (5-chloropyridin-2-ylcarbamoyl) formate | 349125-08-2 | Commercial | ||
| Ethyl (5-chloropyridin-2-ylcarbamoyl) formate Hydrochloride 99% | 1243308-37-3 | Commercial | ||
| 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | 720720-96-7 | Commercial | ||
| tert-Butyl (1R,2S,5S)-2-(2-(5-chloropyridin-2-ylamino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexylcarbamate | 480452-36-6 | Commercial | ||
| N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-ethanediamide | 480449-70-5 | Commercial | ||
| 4 | Atomoxetine Hydrochloride |
Atomoxetine Free Base | 83015-26-3 | Commercial |
| Atomoxetine Mandelate | 131727-12-8 | Commercial | ||
| 5 | Ivacaftor | 4-Oxo-1,4-dihydroquinoline-3-carboxylic acid | 13721-01-2 | Commercial |
| Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate | 52980-28-6 | Commercial | ||
| 5-Amino-2,4-di-tert-butylphenol | 873055-58-4 | Commercial |
| Name of API | CAS Number | Status | Therapeutic Category |
|---|---|---|---|
| Rivaroxaban | 366789-02-8 | CEP Filed | Anti-Coagulant |
| Apixaban | 503612-47-3 | US-DMF Filed | Anti-Coagulant |
| Atomoxetine Hydrochloride | - | CEP Filed | ADHD |
| Edoxaban tosylate monohydrate | 1229194-11-9 | Commercials | Anti-coagulant |
| Escitalopram oxalate | 219861-08-2 | Commercials | Anti-Depressant |
| Ivacaftor | - | Commercials | Cystic Fibrosis |
| Trospium Chloride | - | Tech Pack | Over active Bladder |
| Mirabegron | - | Tech Pack | Over active Bladder |
| Xanomeline Tartrate | - | Tech Pack | Schizophrenia |
| Resmetirom | - | U/Development | NASH |
| Tezacaftor | - | U/Development | Cystic Fibrosis |
| Elexacaftor | - | U/Development | Cystic Fibrosis |
| Atogepant | - | U/Development | Anti-Migraine |
| Vibegron | - | U/Development | Urinary Incontinence/Overactive Bladder |
| Orforglipron | - | U/Development | Anti-Diabetic and Anti-Obesity |
Note: Company does not offer or supply for commercial use, Products protected under valid patents, where the sale of such products constitutes a patent infringement. Only research & development quantities of such products are manufactured and offered for the purpose of regulatory submissions in India and/or other jurisdiction, wherever such regulatory exemptions exist, according to Section 107A of the Indian Patent Act and the corresponding provision of the Patent Act of the respective jurisdiction.
| Impurity Chemical Name | CAS No |
|---|---|
| 2-((S)-2,3-Dihydroxypropyl)isoindoline-1,3-dione | NA |
| 1-{[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid | 144689-63-4 |
| 1-{[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo [3,4-d]imidazol-6(4H)-one | 849206-43-5 |
| (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H- imidazole-5-carboxylate | 879562-26-2 |
| (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2′-(2-trityl-2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate | 1020157-01-0 |
| 2-((S)-2,3-Dihydroxypropyl)isoindoline-1,3-dione | 62457-35-6 |
| 2-((S)-2-Hydroxy-3-methoxypropyl)isoindoline-1,3-dione | NA |
| 4-(4-((S)-3-amino-2-hydroxypropylamino)phenyl)morpholin-3-one | 1403383-56-1 |
| (S)-N1-methyl-N2-((2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl) oxazolidin-5-yl)methyl)phthalamide | NA |
| (S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide | 1429334-00-8 |
| 1, 3-Bis ({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl] oxazolidin-5-yl}methyl)urea | 1365267-35-1 |
| (S)-2-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione | 446292-08-6 |
| 5-chloro-N-(4-nitrophenyl) pentanamide | 1039914-85-6 |
| 3,3-dichloro-1-(4-nitrophenyl) piperidin-2-one | 881386-01-2 |
| 1-(4-aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one | 1267610-26-3 |
| 5-chloro-N-(4-(5-morpholino-6-oxo-3,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide) | 1643330-62-4 |
| Ethyl 1-(4-methoxyphenyl)-7a-morpholino-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-3a,4,5,6,7,7a-hexahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 1619934-76-7 |
| 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid | 503614-92-4 |
| 6-(4-aminophenyl)-4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | 1423803-24-0 |
| 5-(4-(3-Carbamoyl-1-(4-methoxyphenyl)-7-oxo-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-6(7H)-yl) phenylamino) pentanoic acid | 2206825-87-6 |
| "Methyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate" | 1074365-84-6 |